HAMED KAMAL (Chief Medical Officer) received a stock award from SPERO THERAPEUTICS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 2/3/2023ACC: 0000899243-23-003942
Officer· Chief Medical Officer
Since Sep 2022
+265.96K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
265.96K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+265.96K
Price / share
—
Trade value
—
% of position
126.6%
2/1/2023
210K→475.96K
Total
Net shares
+265.96K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/1/2023 | A · Award | +265.96K | — | — | 126.6% | 210K | 475.96K |
| Total | +265.96K | $0.00 | ||||||
Derivative Transactions0
No derivative transactions reported